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Abstract Trace elements have important functions
in several processes involved in cellular homeostasis
and survival. Dysfunctional metal ion homeostasis can
make an important impact on cellular defence mech-
anisms. We assessed the concentrations of 23 trace
minerals in different tissues (brain, spleen, heart and
liver) of Fmr1 knockout (KO) mice that display the
main phenotype of Fragile X syndrome (FXS), an
intellectual disability syndrome and the best-known
monogenic model of autism spectrum disorder (ASD).
Altogether, seven minerals—Cu, Fe, K, Mg, Mn, Na,
and P—were above the detection limit with the
analysis revealing increased iron content in the heart
of Fmr1 KO mice. In addition, levels of iron were
higher in the cerebellum of the transgenic mouse when
compared to wild type controls. These results impli-
cate a role for dysregulated iron homeostasis in FXS
tissues and suggest that defective iron-related mech-
anisms contribute to increased tissue vulnerability in
FXS.
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Introduction
Fragile X syndrome (FXS) is an intellectual disability
syndrome with a prevalence of around 1/4000 in males
and 1/6000–8000 in females (Crawford et al. 1999).
The FXS neurobehavioral phenotype includes abnor-
malities in speech development and communication,
social behaviour, sensory reactivity, attention, arousal,
and activity levels (Hagerman et al. 2010). The vast
majority of FXS males display some behaviours
characteristic of individuals with autism spectrum
disorder (ASD) with some (* 10–30%) fulfilling the
standardised criteria for ASD (Brown et al. 1986).
FXS is a monogenic disorder caused by the absence of
FMR1 protein (FMRP) and the Fmr1 knockout (KO)
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mouse recapitulates the human FXS phenotype. In
most FXS patients, a CGG triple repeat expansion
comprising[ 200 repeats leads to transcriptional
silencing of the FMR1 gene (O’Donnell and Warren
2002). The length of the repeated CGG sequence of
the FMR1 gene in the range of 6–44 repeats is normal,
whereas 45–54 repeats is intermediate or grey area,
and 55–200 repeats is considered as premutation
(Verkerk et al. 1991; Penagarikano et al. 2007). The
premutation causes increased FMR1 mRNA levels
that associates with slightly reduced FMRP expression
and does not result in any neurodevelopmental syn-
drome, but can lead to the onset of Fragile X-associ-
ated Tremor/Ataxia Syndrome (FXTAS) after the age
of 50 years (Loesch and Hagerman 2012).
An inappropriate intake or absorption of trace
elements is associated with a variety of health
problems. Altered metal homeostasis is linked to a
number of disorders and heavy metal exposure is
presented as a potential risk factor for neurodevelop-
mental disorders (Froehlich et al. 2011; Scassellati
et al. 2012; Kanninen et al. 2013). It has been
suggested that metal deficiency and/or toxic metal
burdens may epigenetically contribute to the manifes-
tation of ASD (Yasuda et al. 2013). However, several
studies searching changes of trace elements/metals in
ASD have generated inconsistent results with high
individual variation in levels of minerals (Saghazadeh
et al. 2017; Tseng et al. 2018; Curtin et al. 2018;
Austin et al. 2019; Hassan et al. 2019). Studies of
genetic mouse models of neurodevelopmental dis-
eases could provide important additional information
about the relationship of trace metal balance and ASD.
Metal ions are tightly linked to the redox state of a
cell. Oxidative stress is elevated in the brain of Fmr1
KO mice (El Bekay et al. 2007), but tissue trace
element homeostasis has not been previously exam-
ined in FXS. We investigated biometal concentrations
in different tissues of the Fmr1 KO mice. Using
sensitive inductively coupled plasma mass spectrom-
etry (ICP-MS) to analyse trace elements, seven
minerals were reliably detected in mouse tissues and




Fmr1 KO mice (B6.129P2-Fmr1tm1/Cgr/J, Jackson
Laboratory, Bar Harbor, ME) and their wild type (WT)
littermates were used at the age of 4–5 months.
Genotyping by tail-PCR was performed as previously
described (Bakker et al. 1994). Mice were housed in
groups and subjected to a 12-h light–dark cycle with
access to food and water ad libitum. All animal
experiments were done in accordance with the guide-
lines of the National Institute of Health Guide for the
Care and Use of Laboratory Animals and carried out
using protocols approved by the Experimental Animal
Ethical Committee of Southern Finland.
Mouse tissues
For tissue collection, mice were anaesthetised with
carbon dioxide and sacrificed by cervical dislocation.
Brains, spleens, hearts, and livers were collected.
Cerebellums and the ventral regions of the cerebral
cortex were further dissected. The tissue pieces were
weighed. There were no differences of average wet
weights (p\ 0.05) between control and FXS tissue
samples (Table 1). All tissues were snap frozen and
stored at - 80 C until use.
Mass-spectrometry analysis
The tissue concentrations of trace elements were
measured by an established and fully validated method
using ICP-MS as described previously (Maynard et al.
2002; Kanninen et al. 2013). Due to technical prob-
lems, four samples were not processed (Fmr1 KO
cortex, WT liver and both Fmr1 KO and WT
cerebellum). Briefly, weighed tissue samples were
lyophilised, digested in 100–300 ll of 65% nitric acid
(Merck, Kilsyth, Victoria, Australia) overnight at
room temperature (RT), and heated for 20 min at
90 C. Then an equivalent volume of 30% hydrogen
peroxide (30% Aristar, BDH) was added and samples
were incubated for 30 min at RT, followed by 15 min
at 70 C. The average reduced volume was deter-
mined, and the samples were diluted with 1% nitric
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acid diluent using dilution factors as shown in Table 1.
Volume of digest was the amount of the digested
sample that was used to make the dilution.
Measurements were made with an Agilent 7700
series ICP-MS instrument (Agilent Technologies,
Santa Clara, CA, USA) under routine multi-element
operating conditions using helium as cell gas. The
instrument was calibrated using 0, 5, 10, 50, and
100 ppb of certified multi-element standard calibra-
tion solutions (ICP-MS-CAL2-1, ICP-MS-CAL-3,
and ICP-MS-CAL-4; Accustandard, New Haven,
CT, USA) for the range of the elements and 200 ppb
of Yttrium (Y89) was used as internal control (ICP-
MS-IS-MIX1-1, Accustandard). Three media blanks
were used to determine detection limits. Conversion of
readings in ppb was performed as follows: (lg/
g) = (raw ppb value 9 dilution factor 9 reduced
digest volume)/(tissue wet weight g). Samples were
analysed in triplicate and median values were used for
analyses. Results are expressed in micrograms of
metal per gram of wet (lg/g wet wt). The concentra-
tion of 23 minerals and trace elements were assessed in
mouse heart, liver, spleen, and brain tissues.
Altogether, 7 trace elements (Cu, Fe, K, Mg, Mn,
Na, and P) were above detection limits in our set of
samples (Table 2), whereas 16 trace elements (Al, B,
Ba, Ca, Cd, Co, Cr, Li, Mo, Ni, Rb, Ru, Se, Sr, Ti, and
Zn) could not be reliably detected.
Statistical analysis
Statistical significance between KO and WT mouse
tissues with each variable was determined with the
Student’s t-test. The principal component analysis
(PCA) was performed with all 35 metal variables (7
elements in 5 tissues). In the analysis, two WT mice
were excluded due to several missing values and the
missing values were replaced with the means when
maximum of two tissues were missing. All statistical
analyses, including linear correlations across all
variables, were carried out using IBM SSPS Statistics.
Data are shown as mean ± standard deviation. The
criterion for significance was set to p\ 0.05.
Table 1 Sample preparation












Cerebellum 12 63 ± 5.9 52 ± 8 100 150 21 50
Cortex 12 140 ± 5.2 140 ± 11 100 135 21 50
Heart 14 82 ± 8 59 ± 7 150 210 21 50
Liver 12 170 ± 20 160 ± 17 300 470 51 30
Spleen 13 56 ± 6.9 70 ± 4.4 150 210 21 50
Sample weights are mean ± SEM
Table 2 The absolute
metal content in the set of
WT tissue samples of
average size and
concentrations of the
medium and acid blanks





Na (lg) 210 96 130 38 98 25 32
Mg (lg) 14 7.5 36 9.2 14 0.69 0.31
P (lg) 330 190 530 180 170 4.2 2.5
K (lg) 330 160 500 180 160 4.1 5.4
Mn (ng) 29 21 120 8.2 31 0.013 0
Fe (ng) 910 540 12,000 26,000 3500 0.29 0
Cu (ng) 300 200 720 36 360 0.076 0.0016
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Results
Mean metal concentrations of WT and KO mouse
tissues are presented in Table 3. Most significantly,
iron was increased in the hearts (p = 0.033) of the KO
mice (Fig. 1). The highest iron content was seen in
spleen and the levels were relatively low in the brain
tissues. An increase in iron content in the cerebellum
of the Fmr1 KO was found at the marginal level of
significance (p = 0.052). The methodology suffered
from low power and these statistical significances
should be considered in the context of 35 individual
comparisons (7 metals in 5 tissues) between KO and
WT mice (Bonferroni correction for a typical a = 0.05
with 35 comparisons p\ 0.0014, and the family-wise
error rate for 35 comparisons at a = 0.05 was 0.83).
To evaluate the complete dataset for pattern of
variations, we used the PCA. Three components were
extracted, explaining a total of 73% of the total
variance; PC1 explained 35%, PC2 23%, and PC3
15%. PC1 correlated closely with brain and spleen
variables. PC2 correlated with heart variables and PC3
was influenced mostly by liver variables. T-tests with
Table 3 Concentrations of different metals in heart, spleen, liver, cerebellum, and cortex of Fmr1 KO mice compared to WT
controls
Metal Cortex Cerebellum Liver Spleen Heart
Na (lg/g) WT 1500 ± 97 1500 ± 360 790 ± 110 680 ± 220 1200 ± 230
Fmr1 KO 1500 ± 230 1900 ± 330 730 ± 73 590 ± 160 1400 ± 380
p 0.83 0.21 0.39 0.41 0.19
Mg (lg/g) WT 100 ± 13 120 ± 36 210 ± 19 160 ± 51 170 ± 48
Fmr1 KO 95 ± 18 140 ± 38 210 ± 31 150 ± 34 210 ± 48
p 0.61 0.4 0.8 0.51 0.16
P (lg/g) WT 2300 ± 280 3100 ± 980 3100 ± 240 3200 ± 1000 2100 ± 630
Fmr1 KO 2300 ± 420 3600 ± 1000 3000 ± 430 2900 ± 720 2500 ± 550
p 0.82 0.41 0.5 0.55 0.23
K (lg/g) WT 2400 ± 300 2500 ± 810 2900 ± 190 3200 ± 1000 2000 ± 640
Fmr1 KO 2300 ± 420 3100 ± 800 3100 ± 420 2900 ± 670 2700 ± 600
p 0.67 0.35 0.53 0.49 0.069
Mn (lg/g) WT 0.21 ± 0.014 0.33 ± 0.093 0.71 ± 0.05 0.15 ± 0.064 0.38 ± 0.083
Fmr1 KO 0.19 ± 0.039 0.36 ± 0.097 0.79 ± 0.13 0.16 ± 0.05 0.49 ± 0.15
p 0.39 0.69 0.14 0.69 0.11
Fe (lg/g) WT 6.6 ± 0.91 8.6 ± 2.6 70 ± 15 460 ± 200 43 ± 11
Fmr1 KO 7.6 ± 1.5 13 ± 2.8 66 ± 19 510 ± 190 62 ± 17
p 0.18 0.052 0.74 0.7 0.033 *
Cu (lg/g) WT 2.2 ± 0.27 3.2 ± 1.7 4.2 ± 0.93 0.64 ± 0.21 4.4 ± 1.2
Fmr1 KO 2 ± 0.44 4.4 ± 1.1 4.2 ± 1.2 0.55 ± 0.13 5.5 ± 1.4
p 0.39 0.31 0.96 0.44 0.16
*p\ 0.05
Fig. 1 Concentration of iron across tissues. Values for
individual Fmr1 KO and WT mice are plotted. *p B 0.05
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respect to the genotype on each extracted principal
component showed that KO and WT mice segregated
across PC2 (p = 0.031), but not across PC1 (p = 0.9)
or PC3 (p = 0.99), implicating altered biometal
homeostasis in the heart of the Fmr1 KO mouse.
Subject mice by genotype and variables by the tissue
of the variable are shown in Fig. 2.
Brain and liver metal levels measured in the present
study were comparable to previously reported mea-
surements in mouse and rat tissues (SATO et al. 1996;
Schneider et al. 2014; Garza-Lombó et al. 2018). In
our analysis, within a tissue, metal concentrations
generally correlated positively, but negatively with the
mass of the tissue sample. Furthermore, we observed
that Mg correlated strongly (r[ 0.95) with P and K in
most tissues, whereas Cu correlated strongly with P,
Mg and K in spleens and hearts. A correlation matrix is
provided in Online Resource 1.
Discussion
The present study demonstrated elevations of iron
levels in heart and cerebellum of the Fmr1 KO mouse.
Iron is a redox-active metal and an essential compo-
nent of many proteins involved in biological defence
mechanisms against oxidative stress (Crichton and
Pierre 2001). A moderate increase in stress status has
been previously reported in the adult Fmr1 KO mouse
brain, reflecting a deficient antioxidant system
together with higher levels of reactive oxygen species,
nicotinamide adenine dinucleotide phosphate
(NADPH) -oxidase activation, lipid peroxidation and
protein oxidation (El Bekay et al. 2007). Furthermore,
studies of human FMR1 premutation fibroblasts have
revealed mitochondrial chain dysfunction and abnor-
mally increased reactive oxygen species (ROS) pro-
duction, which responded to chelation of iron with
desferrioxamine mesylate (DFO) (Napoli et al. 2011).
Since the FMR1 premutation alters FMR1 transcript
expression and slightly reduces FMRP levels, the
findings are consistent with involvement of FMRP in
the regulation of iron balance.
FMRP has previously been implicated in protective
mechanisms against injury in heart (Bao et al. 2018).
Overexpression of FMRP was found to alleviate
oxidative stress and apoptosis in damaged cardiomy-
ocytes. Many FXS patients suffer from dilatation of
Fig. 2 Principal component analysis (PCA) that was used to
classify Fmr1 KO and WT mice based on metal content of seven
different metals in five tissues is shown with respect to PC1 and
PC2. KO and WT mice segregated across PC2 (p = 0.031) that
explained 35% of the total variance and correlated with heart
variables. Variables are coded by colour with respect to tissue
studied
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aortic root and mitral valve prolapse that have been
linked to connective tissue dysplasia. There is also
evidence that sympathetic activity augments cardiac
activity and output in FXS more than in healthy
controls (Sreeram et al. 1989). A 1.4-fold increase in
iron content in the heart tissue of Fmr1 KO mouse
provides evidence of pathological cellular processes,
but its impact on heart function remains to be
investigated. The extent of iron toxicity depends on
localisation of the iron complex within the cell e.g.
cytosolic vs. lysosomal, its biochemical form, and the
cellular content of a wide range of antioxidants and
cytoprotective enzymes that can prevent the genera-
tion and propagation of free radical species. Mito-
chondrial iron accumulation in cardiac tissue and brain
is associated with Friedrich ataxia (FRDA). The
excess iron exists as highly localized multifocal
aggregates rather than a diffuse pattern in the tissue
of FRDA patients and iron-mediated toxicity is not
well understood (Llorens et al. 2019).
Region-specific accumulation of iron can particu-
larly contribute to the pathophysiology of brain
diseases due to the decreased ability of neuronal cells
to respond to oxidative stress. Increased iron levels
have been linked to abnormalities of cerebellar
myelination (Beltrán-Navarro et al. 2012; Klocke
et al. 2018; Fernández et al. 2019). Accumulation of
iron in the cerebellum of the Fmr1 KO mice is
especially interesting considering the cerebellar
changes and altered firing rate of neurons in cerebellar
circuitry of Fmr1 KO mice (Koekkoek et al. 2005).
Cerebellar vermis is essential in gating of sensorimo-
tor reactions (Leaton and Supple 1986), and impaired
acoustic startle reflex in human and mouse models of
FXS also supports involvement of cerebellar defects in
FXS. Cerebellum was not studied as a separate brain
region in the oxidative stress study of Fmr1 KO mice
by el Bekay et al. (2007). Mild cerebellar accumula-
tion of iron was previously shown in a subset of FMR1
premutation carriers with FXTAS (Rogers et al. 2016),
who display defective iron and zinc metabolism
(Napoli et al. 2011).
Biometal supplements are used without medical
prescription and are often tested as treatment of
neurodevelopmental disorders when no other treat-
ment is available. Current research data do not provide
sufficient information to formulate recommendations
for use of trace elements/metals (Lyall et al. 2014;
Devilbiss et al. 2017). Iron is important for normal
behavioural development and its deficiency is often
seen in ASD patients (Latif et al. 2002). However,
altered iron levels in ASD may be primarily of
environmental origin and not directly linked to ASD
(Reynolds et al. 2012). Mouse models offer possibil-
ities to investigate disease-related biometal homeosta-
sis and to evaluate the effectiveness of treatments. It is
important to note that accumulation of trace elements
may increase the risk of tissue damage. Our observa-
tion that heart iron content was increased in the FXS
mouse may have clinical impact, because increased
cardiac iron levels can lead to iron overload car-
diomyopathy, a potentially lethal condition. Further-
more, our study suggests that brain region-specific
alterations of iron exist in FXS. Altogether, the present
findings showing accumulation of iron in distinct
Fmr1 KO mouse tissues are fundamental and promote
further research to evaluate role of biometals in FXS
and other neurodevelopmental disorders.
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Foundation and the Academy of Finland.
Author contributions KT: Data curation, Visualisation,
Original draft preparation; KK: Methodology, Data collection;
AW: Supervision, Methodology; MC: Conceptualisation,
Writing the manuscript, and together with JK Project
administration.
Funding Open access funding provided by University of
Helsinki including Helsinki University Central Hospital.
Declarations
Conflict of interest The authors declare that they have no
competing interests.
Open Access This article is licensed under a Creative Com-
mons Attribution 4.0 International License, which permits use,
sharing, adaptation, distribution and reproduction in any med-
ium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative
Commons licence, and indicate if changes were made. The
images or other third party material in this article are included in
the article’s Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons licence and your
intended use is not permitted by statutory regulation or exceeds
the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/.
123
952 Biometals (2021) 34:947–954
References
Austin C, Curtin P, Curtin A et al (2019) Dynamical properties
of elemental metabolism distinguish attention deficit
hyperactivity disorder from autism spectrum disorder.
Transl Psychiatry 9(1):238. https://doi.org/10.1038/
s41398-019-0567-6
Bakker CE, Verheij C, Willemsen R et al (1994) Fmr1 knockout
mice: a model to study fragile X mental retardation. Cell
78(1):23–33. https://doi.org/10.1016/0092-
8674(94)90569-X
Bao J, Ye C, Zheng Z et al (2018) Fmr1 protects cardiomyocytes
against lipopolysaccharide-induced myocardial injury.
Exp Ther Med 16(3):1825–1833. https://doi.org/10.3892/
etm.2018.6386
Beltrán-Navarro B, Matute E, Vásquez-Garibay E et al (2012)
Effect of chronic iron deficiency on neuropsychological
domains in infants. J Child Neurol 27(3):297–303. https://
doi.org/10.1177/0883073811416867
Brown WT, Jenkins EC, Cohen IL et al (1986) Fragile X and
autism: a multicenter survey. Am J Med Genet
23(1–2):341–352. https://doi.org/10.1002/ajmg.
1320230126
Crawford DC, Meadows KL, Newman JL et al (1999) Preva-
lence and phenotype consequence of FRAXA and FRAXE
alleles in a large, ethnically diverse, special education—
needs population. Am J Hum Genet
64(2):495–507. https://doi.org/10.1086/302260
Crichton RR, Pierre JL (2001) Old iron, young copper: from
Mars to Venus. Biometals 14(2):99–112. https://doi.org/
10.1023/a:1016710810701
Curtin P, Austin C, Curtin A et al (2018) Dynamical features in
fetal and postnatal zinc-copper metabolic cycles predict the
emergence of autism spectrum disorder. Sci Adv
4(5):eaat1293. https://doi.org/10.1126/sciadv.aat1293
DeVilbiss EA, Magnusson C, Gardner RM et al (2017) Ante-
natal nutritional supplementation and autism spectrum
disorders in the Stockholm youth cohort: population based
cohort study. BMJ 359:j4273. https://doi.org/10.1136/bmj.
j4273
El Bekay R, Romero-Zerbo Y, Decara J et al (2007) Enhanced
markers of oxidative stress, altered antioxidants and
NADPH-oxidase activation in brains from Fragile X
mental retardation 1-deficient mice, a pathological model
for Fragile X syndrome. Eur J Neurosci
26(11):3169–3180. https://doi.org/10.1111/j.1460-9568.
2007.05939.x
Fernández M, Sierra-Arregui T, Peñagarikano O (2019) The
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